Coss has expertise in both industrial and academic drug development. Prior to joining OSU, he spent eight years working in the Drug Discovery group at GTx, Inc., a pharmaceutical company that develops small-molecule drugs targeting cancer growth pathways. As a research scientist at GTx, he was involved in the discovery, mechanistic characterization, preclinical and clinical safety and efficacy testing of several novel cancer therapeutics. In addition to overseeing the daily operations of the PhASR, Coss applies his expertise in drug development and clinical pharmacology to meet the diverse needs of the many investigators within the Comprehensive Cancer Center.